Stocks · Coverage Archive
$CAPR
6.29 ▼ 7.97%
Every Regards of Wallstreet article on $CAPR, newest first — 2 stories and counting.
2026-08-14 · 9 min read
Why Capricor (CAPR) Rose 58%: The FDA Decision Went Away, and I Called It Wrong
Capricor closed up 57.96% on August 14 after saying it will narrow the deramiocel label and let the FDA move the August 22 PDUFA date. Our preview read the trial data right and the trade wrong.
2026-08-12 · 23 min read
Capricor (CAPR) Narrows to Upper Limb, and the August 22 FDA Date Moves
An activist investor is pushing Capricor's board for a cash freeze and new directors, and STAT News says deramiocel's rejection looks near-certain, a day CAPR fell 8% to $6.29. No replacement PDUFA date has been set.
New to options? See our plain-English strategy playbook →
The Week-Ahead Brief
Don’t miss next week’s setups. Get the Saturday brief.
Latest issue, Aug 17“The consumer cracked on Friday. Six retailers answer for it this week.”
Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.